Cheil Bio Co

Cheil Bio Co Capital Intensity

Delisted·Feb 25, 2026

The Capital Intensity Ratio of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 276.64 %. In the previous year, Capital Intensity Ratio was 223.66 % — a change of 23.68% (higher).

Capital Intensity

276.64 %

YoY

23.68%

Last updated:

Capital Intensity Ratio of Cheil Bio Co is 2023 276.64 % . Capital Intensity Ratio of Cheil Bio Co was 2022 223.66 % . It decreases by 23.68% higher compared to the previous year.

The Cheil Bio Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2016
106.63 KRW
Jan 1, 2017
117.49 KRW
Jan 1, 2018
116.26 KRW
Jan 1, 2019
150.74 KRW
Jan 1, 2020
224.37 KRW
Jan 1, 2021
231.54 KRW
Jan 1, 2022
223.66 KRW
Jan 1, 2023
276.64 KRW
The Cheil Bio Co Capital Intensity history
YEARCapital IntensityYoY
276.64 %+23.68%
223.66 %-3.40%
231.54 %+3.20%
224.37 %+48.85%
150.74 %+29.65%
116.26 %-1.05%
117.49 %+10.18%
106.63 %-5.17%
112.45 %+87.09%
60.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Capital Intensity Ratio of Cheil Bio Co is 276.64 % in 2023.

Capital Intensity Ratio of Cheil Bio Co changed from 223.66 % to 276.64 %, representing a 23.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cheil Bio Co

All Key Metrics — Cheil Bio Co